MedPath

Effect of Repeated tDCS Sessions on Cognitive Improvement in Patients With Disorders of Consciousness

Not Applicable
Completed
Conditions
Post-comatose Non-communicative Patients
Disorders of Consciousness
Severe Brain Injury
Interventions
Device: transcranial direct current stimulation
Registration Number
NCT02394691
Lead Sponsor
University of Liege
Brief Summary

In this study, researchers will show to caregivers of patients how to use a tDCS device (this device was designed to be easy to use, with fixed parameters and only one button to press to run the stimulation). They will be asked to apply a stimulation every day, 5 days per week during for 4 weeks, in chronic patients in minimally conscious state (MCS).

2 sessions of 4 weeks of stimulations will be realized, one anodal and one sham in a randomized order. Before and after each session, behavioral improvement will be assessed with the Coma Recovery Scale Revised (CRS-R). A final assessment will be done 8 weeks after the end of the sessions to assess the long term effect of tDCS.

Detailed Description

A single session of tDCS showed positive effects on patients in MCS (study published in Neurology, 2014). Nevertheless, the effects went down after 1 or 2 hours. In a second study (Protocol ID: 2009/201/B) we have found that 5 days of tDCS increase the lasting of the effects up to one week.

To know if tDCS could be use in clinical daily practice, a new study will evaluate the effects of 20 minutes of tDCS over the left prefrontal dorsolateral cortex for 4 weeks, 5 days per week, in chronic patients in MCS.

2 sessions of 4 weeks of stimulation (total=20 stimulations per session) will be performed, one session will be real (anodal stimulation) and one placebo (sham stimulation).

Firstly, the patient will be seen at the hospital for a behavioral assessment (CRS-R) with one of his/her caregiver. The investigator will explain to the caregiver how to perform the stimulation. In addition, he/she will receive a folder and a video. The caregiver will take an exam to be sure he/she performs the tDCS properly.

Before and after each stimulation session, behavioral improvement will be assessed with the CRS-R by a trained neuropsychologist, at the hospital. A final assessment will be done 8 weeks after the end of the session to assess the long term effect of tDCS.

The compliance will be recorded by the deice to be sure that the caregiver performs the stimulation every day as expected.

Researchers expect to see (a) an improvement of the CRS-R total score at the end of the anodal session and (b) this improvement persists for 8 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • be in an minimally conscious state
  • be chronic (more then 3 months post insult)
  • stable condition
Exclusion Criteria
  • NMDA receptor inhibitor drugs
  • modification of the treatment during the protocol
  • illness or infection during the protocol
  • pacemaker
  • metallic cerebral implant
  • prior neurological disorder
  • tDCS or other non-invasive brain stimulation treatment less than 3months before the inclusion in the present study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
sham stimulationtranscranial direct current stimulationPatients receive a sham tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 5 secondes at the begining and the end of the stimulation to mimic the effects of tDCS). A CRS-R is performed at baseline (before the first stimulation) and after the tDCS session. A final CRS-R is performed 8 week after the end of the session to assess the potential long term effects of tDCS.
anodal stimulationtranscranial direct current stimulationPatients receive an anodal tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes). A CRS-R is performed at baseline (before the first stimulation) and after the tDCS session. A final CRS-R is performed 8 week after the end of the session to assess the potential long term effects of tDCS.
Primary Outcome Measures
NameTimeMethod
Change in the CRS-R total scoreafter each stimulation sessions (4 weeks) and 8 weeks later

Improvement of the CRS-R total score after the end of the anodal session and 8 weeks later but no change for the sham session.

Safety of the device (adverse effect)Recorded after each stimulations sessions (4 weeks) and 8 weeks later

a questionnaire will be asked to the caregivers and family of the patient to know any adverse effect (drowsiness, redness of the skin, epileptic sizure, sign of pain or discomfort).

Usability of the device in daily clinical practice (compliance of the device by the caregivers)After the end of the protocol (24 weeks)

The tDCS device records the number of stimulations performed during the protocol. We will be able to evaluate the compliance of the device by the caregivers to know if they use it properly and as expected.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Liège

🇧🇪

Liège, Belgium

© Copyright 2025. All Rights Reserved by MedPath